Awarded

Suministro de medicamento exclusivo Ravulizumab

Name: Suministro de medicamento exclusivo Ravulizumab
Creator: Hospital Infantil Universitario Niño Jesús
Published: 2026-09-15
License: https://ted.europa.eu/en/simap/legal-notice

Track this recordFree account — get alerted when a contract here runs out.

Buyer: Hospital Infantil Universitario Niño Jesús
Winners: ALEXION PHARMA SPAIN, S.L.
Contract value: €157,771
Bids received: 1
Published: 15 Sept 2026
Awarded: 9 Sept 2026
Contract start: 9 Sept 2026
Contract end: 10 Sept 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Madrid
Source: Original notice on TED (636520-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
Vosoritida 0,8 mg/ml inyectable	Hospital Infantil Universitario Niño Jesús	BIOMARIN PHARMACEUTICALS ESPAÑA S.L.	€195,578	1 Sept 2026
Elosulfasa alfa 1 mg/ml inyectable 5 ml	Hospital Infantil Universitario Niño Jesús	BIOMARIN PHARMACEUTICALS ESPAÑA S.L.	€123,362	1 Sept 2026
Cerliponasa alfa 150 mg iny perf vial	Hospital Infantil Universitario Niño Jesús	BIOMARIN PHARMACEUTICALS ESPAÑA S.L.	€457,080	1 Sept 2026
Medicamento exclusivo Setmelanotida 10 mg/ml inyectable 1 ml (envase 1 vial)	Hospital Infantil Universitario Niño Jesús	EUROMED PHARMA SPAIN S.L.	€424,819	28 Aug 2026
Material fungible asociado a bombas de infusión volumétricas mod PLUM 360	Hospital Infantil Universitario Niño Jesús	ICU MEDICALPRODUCTOS FARMACEÚTICOS Y HOSPITALARIOS, S.L.	€139,918	27 Aug 2026
Suministro de medicamento exclusivo Ravulizumab	Hospital Infantil Universitario Niño Jesús	ALEXION PHARMA SPAIN, S.L.	€157,771	11 Aug 2026